Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 Common Stock

Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 (CYCCP) currently reports a common stock of $7K as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10's common stock history and peer comparisons.

Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10's common stock changed from $0 to $7K (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 reported $7K in common stock as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $7K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10, and consider following CYCCP for alerts when major investors trade the stock.

Cyclacel Pharmaceuticals- 6% PRF PERPETUAL USD 10 is classified in the Healthcare sector. On common stock, it currently shows $7K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYCCP with unrelated industries.